Health Professional Radio - Podcast

Returning guest, Dr. David Spetzler, President and Chief Scientific Officer and Dr. Jim Abraham, Senior Vice President and Chief Data Officer at Caris Life Sciences discuss positive results from validation studies of MI FOLFOXai™, Caris Life Sciences’ artificial intelligence (AI)-based predictor that gauges a metastatic colorectal cancer (mCRC) patient’s likelihood of benefiting from the sequence of two first-line, standard of care treatments. These results were published in "Clinical Cancer Research" a publication of the "American Association for Cancer Research". David Spetzler, MS, Ph.D., MBA, President and Chief Scientific Officer. Dr. Spetzler joined Caris Life Sciences® in August of 2009 and has held several management positions with increasing responsibilities during his tenure. He leads the company’s clinical testing service and development of proprietary technologies to aid in the creation of precision medicine strategies for individual cancer patients and noninvasive technologies to identify and p